Litcius/Paper detail

Synthesis, study of antileishmanial and antitrypanosomal activity of imidazo pyridine fused triazole analogues

Adinarayana Nandikolla, Singireddi Srinivasarao, Banoth Karan Kumar, Sankaranarayanan Murugesan, Himanshu Aggarwal, Louise L. Major, Terry Smith, Kondapalli Venkata Gowri Chandra Sekhar

2020RSC Advances33 citationsDOIOpen Access PDF

Abstract

toxicity profile suggested that the tested compounds would be non-toxic, which was confirmed experimentally by the lack of cytotoxicity against HeLa cells. Finally, a molecular docking study was also performed, for 10d the most active antileishmanial compound, to study its putative binding pattern at the active site of the selected leishmanial trypanothione reductase target.

Topics & Concepts

ChemistryIn silicoStereochemistryLipinski's rule of fiveHeLaADMEPyridineDocking (animal)1,2,3-TriazoleCytotoxicityActive siteTrypanosoma bruceiBromideStructure–activity relationshipIn vitroBiochemistryEnzymeOrganic chemistryNursingGeneMedicineResearch on Leishmaniasis StudiesTrypanosoma species research and implicationsClick Chemistry and Applications
Synthesis, study of antileishmanial and antitrypanosomal activity of imidazo pyridine fused triazole analogues | Litcius